BioSpace News Archive

Eurofins DiscoverX, the products company of Eurofins Discovery, today announced the expansion of their CRO Certification Program for Bioassays with Catalent Biologics as a North American provider c

Castlight Health, Inc. (NYSE: CSLT) today announced the availability of its behavioral health solution to help employees easily access and navigate behavioral health support and resources amidst the COVID-19 pandemic

Echosens , a high-technology company offering the FibroScan family of products, today announces the release of its white paper authored by Dr. Reed Hogan, M.D., GI Associates (GIA) in Flowood, Mississippi, “ Understanding the Many Benefits of Comprehensive, Chronic Care Management (CCM) of Liver Dis

Diagnostic laboratories continue to be a crucial part of nationwide efforts to provide access to COVID-19 testing, which is critical to managing the pandemic.

First dosing of Tacrolimus Inhalation Powder initiates development program for direct-to-lung delivery of a Thin Film Freezing dry-powder product for prevention of lung transplant rejection Phase 1 topline data indicates safety of single doses of Voriconazole Inhalation Powder up to 80 mg/dose in healthy subjects for direct-to-lung delivery of voriconazole for Invasive Pulmonary Aspergillosis AUSTIN, Texas--( BUSINESS WIRE )-- TFF Pharmaceutic

- Live on-air interview to feature Citius CEO on Tuesday, June 30th at 1:20pm ET - CEO to discuss potential use of Induced Mesenchymal Stem Cells (iMSCs) for the treatment of acute respiratory distress syndrome (ARDS) in patients with COVID-19 - Company to provide update about ongoing Phase 3 FDA Trial for Mino-Lok® [29-June-2020] CRANFORD, N.J. , J

Turret Capital Management, a global venture building and investment firm focused on the healthcare industry, has signed a Definitive License Agreement with Or-Genix Therapeutics, Inc. Under the terms of the agreement, Turret Capital has obtained global co-development rights for a family of breakthrough, topically-acting, proprietary small m

Synergy Laboratories (Synergy) announced today that it is now able to test for the presence of key antibodies to the coronavirus. Individuals infected with the coronavirus produce IgM and IgG antibodies and identifying these antibodies can play a crucial role in understanding the degree of immunity a COVID-19 survivor has developed. Brad Pitts , Synergy’s Chief Executive Officer said, “Once we can determine the leve

Kyowa Kirin USA Holdings, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, named Ana Bastiani-Posner , MBA, a proven leader with over 20 years of financial experience, as its Executive Vice President, Chief Financial Officer, effective June 29 . Ms. Bastiani-Posner

Tufts Health Plan Foundation board approved an additional $900,000 to support recovery and rebuilding efforts addressing the effects of the coronavirus pandemic in Massachusetts, Rhode Island, New Hampshire and Connecticut.